08.03.12
Thorne Research, Inc., Sandpoint, ID, manufacturer of nutritional supplements and personal care products, and Helsinn, a pharmaceutical group based in Lugano, Switzerland, have announced the launch of the OncoQOL product line — a portfolio of 13 nutritional supplements intended to support the unique nutritional needs of patients undergoing cancer treatment. The OncoQOL portfolio also includes the DermaQOL product line, with nine organic personal care products specially formulated to support the skin and hair care needs of patients undergoing cancer treatment. OncoQOL products, including the DermaQOL product line, are available only through oncologists and other medical professionals in the U.S. and Canada.The OncoQOL product line is designed to help patients address the side effects of cancer treatment such as weight loss, fatigue, diarrhea, and highly sensitive nerves and skin, which can deteriorate patients’ quality of life and adversely affect compliance in fully completing their course of treatment.